UK Startup Respiro Diagnostics Raises £1 Million to Develop Breath-Based Lung Diagnostics
Respiro Diagnostics, a UK-based startup developing non-invasive breath-based diagnostics for lung diseases, raised £1 million in pre-seed funding led by Zinc Venture Capital and SFC Capital. The technology uses exhaled breath to detect lung cancer and other respiratory conditions, offering an alternative to invasive biopsies.